Asia Pacific Antibody Discovery Market Forecast to 2030

At 7.3% CAGR, Asia Pacific Antibody Discovery Market is Speculated to be Worth US$ 11,58,681.86 Million by 2030, says The Research Team

According to The Research Team’ research, the Asia Pacific antibody discovery market was valued at US$ 6,58,965.05 million in 2022 and is expected to reach US$ 11,58,681.86 million by 2030, registering a CAGR of 7.3% from 2022 to 2030. Rising incidence of cancer and proliferation of biotechnology industry in developing regions are among the critical factors attributed to drive the Asia Pacific antibody discovery market growth.

As per the Global Cancer Observatory (GLOBOCAN) estimates published in 2020, there were 19.3 million cancer cases across the world. The GLOBOCAN further estimates that the cancer cases in India would reach ~2.08 million by 2040, representing a rise of 57.5% from 2020. Similarly, as per the World Health Organization (WHO) data published in February 2022, ~10 million people have died from cancer worldwide. By January 2030, the population of cancer survivors is estimated to reach 22.1 million, which can be primarily associated with the aging of the population. Lung, breast, colorectal, prostate, and breast are among the most commonly reported cancer types. The rising incidences of cancer have raised concerns worldwide. Below is the list of common cancer cases reported worldwide in 2020.

New Cancer Cases Worldwide, in 2020

Sr. No.

Cancer Type

Number of Cases (Million)

1

Stomach

1.09

2

Skin (non-melanoma)

1.2

3

Prostate

1.41

4

Colon and rectum

1.93

5

Lung

2.21

6

Breast

2.26

Source: World Health Organization, February 2020

Cancer is now a lifestyle disease commonly seen among people with unhealthy eating habits and those who don’t engage much in physical activities. The frequent consumption of alcohol and tobacco adds up to the risk of developing cancer. Chronic infectious diseases in low- and middle-income countries can further aggravate the cancer risk factors. An upsurge in the incidence of cancer indicates the need for innovative cancer treatments. Monoclonal antibodies represent a promising class of targeted anticancer agents that enhance the natural ability of immune systems to suppress cancer cell activity and eliminate cancer cells. Antibody–drug conjugates (ADCs) have also shown promising results in cancer treatment. Further, progress in modern biotechnology allows researchers and companies to provide well-designed novel antibodies, paving the way for successful treatments of various types of cancer. Thus, the burgeoning incidence of different types of cancer boosts the antibody discovery market growth.

On the contrary, high cost of production hampers the growth of Asia Pacific antibody discovery market.

Based on antibody type, the Asia Pacific antibody discovery market is segmented into monoclonal antibodies, polyclonal antibodies, and others. The monoclonal antibodies segment held 83.8% market share in 2022, amassing US$ 552.16 billion. It is projected to garner US$ 992.92 billion by 2030 to register 7.6% CAGR during 2022–2030.

In terms of nature, the Asia Pacific antibody discovery market is segmented into human and humanized, chimeric, and murine. The human and humanized segment held 57.2% share of Asia Pacific antibody discovery market in 2022, amassing US$ 377.19 billion. It is anticipated to garner US$ 686.55 billion by 2030 to expand at 7.8% CAGR during 2022–2030.

By services, the Asia Pacific antibody discovery market is divided into phage display, hybridoma, transgenic animal, single cell, and yeast display. The phage display segment held 37.0% share of Asia Pacific antibody discovery market in 2022, amassing US$ 243.81 billion. It is projected to garner US$ 450.14 billion by 2030 to expand at 8.0% CAGR from 2022 to 2030.

Based on end user, the Asia Pacific antibody discovery market is categorized into pharmaceutical and biotechnology companies, research laboratories, and others. The pharmaceutical and biotechnology companies segment held 55.1% share of Asia Pacific antibody discovery market in 2022, amassing US$ 363.35 billion. It is predicted to garner US$ 665.94 billion by 2030 to expand at 7.9% CAGR between 2022 and 2030.

Based on country, the Asia Pacific antibody discovery market is categorized into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. Our regional analysis states that China captured 30.5% share of Asia Pacific antibody discovery market in 2022. It was assessed at US$ 200.98 billion in 2022 and is likely to hit US$ 364.52 billion by 2030, registering a CAGR of 7.7% during 2022-2030.

Key players operating in the Asia Pacific antibody discovery market are Charles River Laboratories International Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp, and Biocytogen Pharmaceuticals Beijing Co Ltd, among others.

In January 2024, BiocytogenPharmaceuticals Co Ltd launched a new sub-brand, RenBiologics, to represent the company’s antibody discovery business division. RenBiologics business will cover out-licensing/co-development of the company’s extensive library of fully human antibodies, as well as licensing of RenMice, the company’s fully human antibody/ TCRdiscovery platforms. In August 2023, Twist Bioscience Corp announced a drug discovery agreement with Ono Pharmaceutical Co Ltd to discover and develop novel antibodies for the treatment of autoimmune diseases.

o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antibody discovery market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific antibody discovery market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 The Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.1 Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Investments in Research & Development
4.2.2 Rising Incidence of Cancer
4.3 Market Restraints
4.3.1 High Cost of Production
4.4 Market Opportunities
4.4.1 Proliferation of Biotechnology Industry in Developing Regions
4.5 Future Trends
4.5.1 Developments for Custom Antibodies
4.6 Impact of Drivers and Restraints:
5. Antibody Discovery Market – Asia Pacific Market Analysis
5.1 Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020–2030
6. Asia Pacific Antibody Discovery Market Analysis – by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Antibody Discovery Market Analysis – by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Antibody Discovery Market Analysis – by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Antibody Discovery Market Analysis – by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Antibody Discovery Market – Country Analysis
10.1 Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Asia Pacific: Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China
10.1.1.1.1 Overview
10.1.1.1.2 China: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 China: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 China: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 China: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Japan
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Japan: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Japan: Antibody Discovery Market Breakdown, by End User
10.1.1.3 India
10.1.1.3.1 Overview
10.1.1.3.2 India: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 India: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 India: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 India: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Australia
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Australia: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Australia: Antibody Discovery Market Breakdown, by End User
10.1.1.5 South Korea
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Asia Pacific
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 BioDuro LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Aragen Life Sciences Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Twist Bioscience Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Biocytogen Pharmaceuticals Beijing Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Research Team
13.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 4. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 5. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 6. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 7. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 8. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 9. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 10. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 11. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 12. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 13. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 14. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 16. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 17. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 18. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 19. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 20. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 21. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 22. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 23. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 24. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 25. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 26. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market

LIST OF FIGURES

Figure 1. Asia Pacific Antibody Discovery Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 – 2030
Figure 4. Asia Pacific Antibody Discovery Market Share (%) – by Antibody Type (2022 and 2030)
Figure 5. Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Antibody Discovery Market Share (%) – by Nature (2022 and 2030)
Figure 9. Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Antibody Discovery Market Share (%) – by Services (2022 and 2030)
Figure 13. Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Antibody Discovery Market Share (%) – by End User (2022 and 2030)
Figure 19. Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Antibody Discovery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 26. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Antibody Discovery Market